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Neither the worms nor the larvae are
transmitted person to person, and the
worms can only reproduce in their hu-
man hosts.
Donald Hopkins, who retired as dep-
uty director of the National Centers for
Disease Control and Prevention and is
now with former President Jimmy
Carter's private health program, Global
2000, has waged a quietly effective, per-
sonal campaign against the disease for
many ofthe past 25 years.
Hopkin's eradication strategy includes
two simple but remarkably effective
objectives. First, all persons in epidemic
areas are given fine mesh cloth and taught
to filter their drinking water. Second,
health education programs are imple-
mented to encourage persons to stay away
from the community water supply when
the worms are emerging from their bod-
ies. As a result ofthis approach the num-
ber ofpersons newly infected with guinea
worm has decreased from about one mil-
lion per year to a few hundred thousand
per year over the past three years. If the
present trend in disease incidence contin-
ues, the disease will be eradicated within
three to five years.
Former President Carter has helped
raise over $40 million in contributions
from a variety of sources to support the
eradication campaign. He also visited
epidemic areas in eastern Africa in August
to call attention to the international
effort. Carter's prestige and influence in
developing nations have lent importance
and credibility to the guinea worm eradi-
cation effort among high-level govern-
ment officials and among the residents of
the epidemic areas.
Ifthe project is successful, a low-tech-
nology, environmental public health
intervention strategy will be responsible
for the eradication of one of the most
gruesome parasitic diseases known.
EPA Nominations Made
President Clinton has made nominations to
fill key assistant administrator positions in
the program offices at the Environmental
Protection Agency. After the candidates are
confirmed by the Senate, they will manage
the implementation ofthe categorical envi-
ronmental protection activities defined in
federal law.
Lynn Goldman has been nominated as
assistant administrator for prevention, pesti-
cides, and toxic substances. Goldman, a
toxicologist with the California Department
ofHealth Services, will manage EPA's pro-
grams in pollution prevention, pesticides,
and toxics programs. Toxics programs
include the activities authorized under the
Toxic Substances Control Act and Federal
Insecticide, Fungicide, and Rodenticide
Act. Goldman served as a counselor to the
National Toxicology Program.
Mary Nichols, an attorney with the
National Resources Defense Council in Los
Angeles, has been nominated as assistant
administrator for air and radiation. She will
manage the implementation ofthe Clean Air
Act amendments, the radon and other radia-
tion programs, and the
indoor air pollution control
activities at EPA. Nichols
was California Secretary of
Environmental Affairs and
chair of the California Air
Resources Board from 1979
to 1982.
Robert Perciasepe has
been nominated as assistant
administrator for water.
Perciasepe, Secretary for the
Environment in Maryland,
will manage the EPA pro-
grams authorized by the
Clean Water Act and the
Safe Drinking Water Act.
These federal statutes are
due to be reauthorized by Congress and have
majorimpactsatthestate andlocal levels.
The nominee for assistant administrator
for solid waste and emergency response is
Elliot Laws. Laws, an attorney in private
practice in Washington, DC, will adminis-
ter the Superfund hazardous waste program
and the federal activities related to the dis-
posal of municipal solid waste. The
Superfund Program has been widely criti-
cized by community groups, industry, and
environmentalists and is scheduled for reau-
thorization in the next session ofCongress.
Laws has considerable federal experience as
a litigator in the Department of Justice
Land and Natural Resources Division from
1985 to 1987 and in the Office of
Enforcement and Compliance Monitoring
at the EPA.
Bailus Walker has withdrawn his candi-
dacy for assistant administrator for Research
and Development. Walker, dean of the
School ofPublic Health at the University of
Oklahoma, cited unreasonably long delay in
the nomination and clearance process and
his commitment to the university in the let-
ter explaining his withdrawal.
Administration officials have not yet pro-
posed another candidate, and it is not
known when an administrator of this
important program office that manages the
engineering and health research activities
for EPAwill be named.
New NIH Director
Harold Varmus, a cell biologist from the
University ofCalifornia at San Francisco,
was nominated by President Clinton on
August 4 to direct the National Institutes
of Health. In announcing the nomina-
tion, Secretary of Health and Human
Services Donna Shalala described the
appointment as "absolutely first rank."
As the director of NIH, Varmus will
manage the largest and most complex bio-
medical research effort in the world. The
NIH is made up of 24 institutes, centers,
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and divisions. Among these
are the National Cancer
Institute, the National
Institute of Allergy and In-
fectious Diseases, and a clini-
cal center at its 300-acre head-
quarters in Bethesda, Mary-
land, and the National Insti-
tute ofEnvironmental Health
Sciences in Research Triangle
Park, North Carolina. The
NIH has about 15,000 em-
ployees and an annual budget
ofabout $11 billion. Approx-
imately 80% ofthe NIH bud-
get supports research and
training grants to scientists
throughout the United States.
American preeminence in medicine and
human biology and physiology is attrib-
uted largely to the NIH program ofextra-
mural research grants and intramural sci-
ence that have been developed over the
past 40 years.
Varmus takes over NIH at a critical
period. Each week brings a report of
major new findings in the fundamental
mechanisms of disease and in the treat-
ment of previously intractable conditions.
But even as these achievements are an-
nounced, NIH is not prospering as it has
in the past. Traditionally, Congress
exempted the NIH from budget cuts often
exacted on other domestic programs. In
the 1980s, the NIH budget increased dra-
matically; in the past two years this trend
has not continued. The NIH appropria-
tion has not kept pace with inflation.
Thus, the number of new grant applica-
tions funded by NIH has not grown, and
university-based scientists are frustrated by
the fact that their research proposals
receive high marks in peer review yet are
not funded by NIH. Support for funda-
mental, nontargeted research, long a staple
ofthe NIH grant system, has decreased as
NIH is pressed to be more responsive in
applying research to the resolution of the
immediate health needs of victims of
AIDS and ofwomen, the elderly, and the
poor. Allegations ofscientific fraud on the
part of a few NIH and NIH-supported
researchers and recent reports of sexual
harassment and failure to promote minori-
ties and women have eroded some of the
public's confidence in science and in the
management ofNIH.
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Varmus's record of achievement sug-
gests that he will meet the challenges con-
fronting him as new director. In 1989,
Varmus was awarded the Nobel Prize in
Medicine for discovering oncogenes and
describing their role in the molecular biol-
ogy of cancer. His research interests also
include viruses involved in human disease.
In addition to his research, Varmus taught
several basic science courses to students at
the UC-San Francisco Medical School.
He studied English at Amherst as an
undergraduate and received a master's
degree in English literature from Harvard
before graduating from medical school at
Columbia University. Varmus spent two
years at NIH in the 1970s as a clinical
associate in the National Institute of
Arthritis and Metabolic Diseases.
In what may become a blueprint for
the administration of the NIH under his
leadership, Varmus co-authored a forceful
plea to President Clinton and Vice Pres-
ident Gore for support for science in the
22 January 1993 issue of Science. In a
Policy Forum article, Varmus stressed the
potential benefits of science in resolving
the health, environmental, and economic
problems facing the nation. He went on
to make 11 specific recommendations to
help realize the potential ofscience. Some
of these recommendations included devel-
oping an economic strategy to encourage
investment in biomedical research, encour-
aging technology research in the private
sector, and stimulating alliances between
industry and academia, establishing NIH
as an independent federal agency, and
strengthening the position ofthe presiden-
tial advisor on science and technology.
The nomination of Varmus must be
approved by the Senate. Ifconfirmed, he
will be in a powerful posi-
tion to implement his rec-
ommendations at NIH.
Varmus will have one
important ally in his new
position. In July, the Sen-
ate confirmed President
Clinton's appointment of
Phillip R. Lee as assistant
secretary for health in the
Department of Health and
Human Services. Lee will
be Varmus's immediate su-
perior in the Public Health
Service. Lee returned to
Washington (he was assis-
tant secretary for health in the Johnson
administration) from the UC-San Fran-
cisco where he directed the Institute of
Health Policy. Earlier, Lee was dean ofthe
medical school where Varmus taught and
conducted research. Lee has a long history
ofcontributions in the field ofhealth care




Philip R. Lee-a deep interest
in health care reform.
involved in developing the health care
reform agenda for the Clinton administra-
tion.
Arsenic and New Data
Exposure to high levels ofinorganic arsenic
through inhalation or ingestion causes can-
cer, a fact that was never challenged at the
July 28-30 International Conference on
Arsenic Exposure and Health Effects.
Hours of conference presentations and
debate centered instead on ways to use data
on documented health effects from high
arsenic exposures to predict effects at the
lower levels commonly seen in U.S. com-
munities. Keynote speaker Warner North
of Decision Focus, Inc., emphasized that
there are significant, unresolved issues "in
extrapolating from worst case scenarios"
and suggested it may be necessary to move
beyond standard risk assessment methods
when evaluating the carcinogenicity of
arsenic. Arsenic exposure occurs most
commonly in the U.S. from dietary intake,
soil or dust around old mine and smelter
operations, coal fly ash, and the use of
arsenical pesticides.
An arsenic standard for drinking water
must be proposed by September 1994 to
satisfy a court order against EPA. Charles
Abernathy, a toxicologist with the Risk
Assessment Branch ofEPA and co-chair of
the conference, said that a crucial compo-
nent ofEPA's risk assessment is Taiwanese
research which links skin cancer to high
levels of arsenic in drinking water. More
recent studies in Taiwan also found inter-
nal organ cancers (e.g., bladder and kidney
cancers) in the population studied.
The lead author ofthe Taiwanese stud-
ies, C.J. Chen, presented new data show-
ing not only cancer but also
an elevated risk of ischemic
heart disease among residents
of southwest Taiwan who
drank water with high levels
ofarsenic. Previous studies of
well water in this area of
Taiwan found arsenic levels
between 10 and 1820 micro-
grams per liter (fig/l).
The current U.S. standard
for arsenic in drinking water is
50 pg/l. Several EPA repre-
sentatives indicated that an
EPA risk assessment, based
on the Taiwan skin cancer
data, would likely result in a proposed
standard of 2-5 pg/l of arsenic; the num-
ber would be even lower if the internal
organ cancers are part ofthe equation.
Requiring all water systems in the
country to comply with a 2 ,ug/l standard
would cost $6.3 billion, according to J.
Alan Roberson of the American Water
Works Association (AWWA). The highest
impact would be on Western states, where
water generally has higher arsenic levels.
Other water utility speakers urged EPA
to seek an extension ofits deadline to accu-
mulate more scientific and economic feasi-
bility data, arguing that the population in
Taiwan is significantly different from the
U.S. population. Chen agreed that diet
and socioeconomic characteristics between
his study population and the typical U.S.
community vary, but said his studies pro-
vide persuasive evidence that inorganic
arsenic causes human cancer.
Conference attendees agreed that much
more research needs to be conducted on
the mechanism of arsenic carcinogenicity,
especially in the areas ofpharmacokinetics
and metabolism. There is convincing data
that inorganic arsenic causes human can-
cer, but no animal model has been able to
reproduce the effect. A key research ques-
tion, participants agreed, is the dynamic of
how much inorganic arsenic is ingested,
how much is delivered to internal organs,
and how much is converted to methylated
forms and excreted.
A heated topic of debate was whether
there is a linear dose-response relationship
for arsenic or if instead there might be a
threshold at which ingested arsenic fails to
cause a cancer risk. Roberson told EHP
that the EPA drinking water standard for
arsenic could remain unchanged ifthere is
a threshold for cancer at 50 or 100 pg/l.
Allan Smith of the University of Cali-
fornia, Berkeley, on the other hand, has
argued that the available evidence does not
support a threshold theory. He told the
audience, "Until you have studies at low
dose rates you have to extrapolate." [See
Smith AH, "Cancer Risks from Arsenic in
Drinking Water," EHP 97: 259-267
(1992).]
Co-chair Abernathy believes the con-
ference met its aim: to allow rational dis-
cussion of the Taiwan data among people
with diverse views, ranging from analytical
chemists to water works engineers to envi-
ronmentalists. The conference "made clear
the uncertainties of the economic impact
and health impact of regulating arsenic,"
Willard Chappell of the University of
Colorado, Denver, told EHP. Chappell
urged EPA to consider all new research
data when making its regulatory decisions,
warning, "billions of dollars are at stake
here."
The three-day conference was spon-
sored by the Society of Environmental
Geochemistry and Health, the Agency for
Toxic Substances and Disease Registry,
EPA, the American Water Works Assoc-
iation, Atlantic Richfield Co. (ARCO), the
American Mining Congress, the Electric
Power Research Institute, the International
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